SB 75

Known as: SB-75 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2015
051019882015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
OBJECTIVE Our objective was to study the direct action of the gonadotropin-releasing hormone antagonist SB-75 and the agonist… (More)
Is this relevant?
1994
1994
Female athymic nude mice bearing xenografts of OV-1063 human epithelial ovarian cancer cell line were treated with potent… (More)
Is this relevant?
1994
1994
Among new highly potent antagonistic analogs of luteinizing hormone-releasing hormone (LH-RH), containing neutral hydrophilic D… (More)
Is this relevant?
1993
1993
Nude mice bearing xenografts of the MIA PaCa-2 human pancreatic cancer cell line were treated with sustained-release formulations… (More)
Is this relevant?
1993
1993
The involvement of IGFs in growth regulation of the Ishikawa endometrial tumor cell line and the possible interference of LH-RH… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Although specific binding sites for LH-releasing hormone (LHRH) and its analogs have been demonstrated in biopsy samples of human… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Recently, specific binding sites for luteinizing hormone releasing hormone (LHRH) and its analogues have been demonstrated in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1991
1991
The reversibility of the antifertility effects induced by long-term administration of the LH-RH antagonistic analog [Ac-D-Nal(2)1… (More)
Is this relevant?
1990
1990
Female BDF1 mice bearing MXT mammary adenocarcinomas were treated for 3 weeks with the luteinizing hormone-releasing hormone (LH… (More)
Is this relevant?